Author | Ashley Roberts

Articles

Court Blocks First FDA-Approved Biosimilar

The US Court of Appeals granted Amgen’s request to block Novartis’ Neupogen biosimilar, Zarxio, from the US market until the court resolves litigation between the two companies.